90 results on '"Felker, G"'
Search Results
2. Natriuresis-Guided Titration of Loop Diuretics in Heart Failure: Another Brick in the Wall
3. Echocardiographic Features Beyond Ejection Fraction and Associated Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction
4. Heart Failure Across the Range of Mildly Reduced and Preserved Ejection Fraction in the United States
5. Mechanistic Efficacy of Sacubitril/Valsartan in Ischemic Versus Nonischemic Heart Failure
6. Association Between Sacubitril/Valsartan Initiation and Mitral Regurgitation Severity in Heart Failure With Reduced Ejection Fraction: The PROVE-HF Study
7. Catastrophic Disruptions in Clinical Trials
8. Clinical Prediction Models for Heart Failure Hospitalization in Type 2 Diabetes: A Systematic Review and Meta‐Analysis
9. Developments in Exercise Capacity Assessment in Heart Failure Clinical Trials and the Rationale for the Design of METEORIC-HF
10. Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction After a Recent Worsening Heart Failure Event
11. Probabilistic Readjudication of Heart Failure Hospitalization Events in the PARAGON-HF Study
12. Association Between Angiotensin Receptor–Neprilysin Inhibition, Cardiovascular Biomarkers, and Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction
13. Differences in NT‐proBNP Response and Prognosis in Men and Women With Heart Failure With Reduced Ejection Fraction
14. Mechanisms and Models in Heart Failure
15. Ultrafiltration in Acute Heart Failure: Implications of Ejection Fraction and Early Response to Treatment From CARRESS‐HF
16. Cardiac Myosin Activator Omecamtiv Mecarbil Improves Left Ventricular Myocardial Deformation in Chronic Heart Failure
17. Racial Differences in Serial NT-proBNP Levels in Heart Failure Management
18. Heart Failure Clinical Trial Operations During the COVID-19 Pandemic
19. Challenges and Potential Improvements to Patient Access to Pharmaceuticals
20. Obese-Inflammatory Phenotypes in Heart Failure With Preserved Ejection Fraction
21. Racial Differences in Diuretic Efficiency, Plasma Renin, and Rehospitalization in Subjects With Acute Heart Failure
22. Biomarkers in Advanced Heart Failure
23. Comparative Effectiveness of Primary Prevention Implantable Cardioverter‐Defibrillators in Older Heart Failure Patients With Diabetes Mellitus
24. Effects of Liraglutide on Worsening Renal Function Among Patients With Heart Failure With Reduced Ejection Fraction
25. Provider Perspectives on the Feasibility and Utility of Routine Patient‐Reported Outcomes Assessment in Heart Failure: A Qualitative Analysis
26. Building the Foundation for a New Era of Quadruple Therapy in Heart Failure
27. Rhythm Control Versus Rate Control in Patients With Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction: Insights From Get With The Guidelines—Heart Failure
28. Clinical Implications of the New York Heart Association Classification
29. Abstract 933: Integrated Omics Analysis of Diabetic Heart Failure in Human Myocardium
30. Renal Effects of Intensive Volume Removal in Heart Failure Patients With Preexisting Worsening Renal Function
31. Suppression of Tumorigenicity 2 in Heart Failure With Preserved Ejection Fraction
32. High‐Sensitivity Troponin I in Hospitalized and Ambulatory Patients With Heart Failure With Preserved Ejection Fraction: Insights From the Heart Failure Clinical Research Network
33. Dose Response of β-Blockers in Adrenergic Receptor Polymorphism Genotypes
34. Trends in Noncardiovascular Comorbidities Among Patients Hospitalized for Heart Failure
35. Worsening Renal Function in Patients With Acute Heart Failure Undergoing Aggressive Diuresis Is Not Associated With Tubular Injury
36. Machine Learning Methods Improve Prognostication, Identify Clinically Distinct Phenotypes, and Detect Heterogeneity in Response to Therapy in a Large Cohort of Heart Failure Patients
37. Abstract 122: Comparative Effectiveness of Primary Prevention Implantable Cardioverter-Defibrillators in Older Adults With Diabetes Mellitus: Insights From the Get With the Guidelines - Heart Failure Registry
38. Interaction of Body Mass Index on the Association Between N‐Terminal‐Pro‐b‐Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From ASCEND‐HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure)
39. Plasma Levels of MicroRNA-155 Are Upregulated with Long-Term Left Ventricular Assist Device Support
40. Role of Volume Redistribution in the Congestion of Heart Failure
41. Accelerometer-Measured Daily Activity in Heart Failure With Preserved Ejection Fraction
42. Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association
43. Soluble ST2 in Heart Failure With Preserved Ejection Fraction
44. Pulmonary Hypertension in the Era of Mechanical Circulatory Support
45. Metabolomic Profiling Identifies Novel Circulating Biomarkers of Mitochondrial Dysfunction Differentially Elevated in Heart Failure With Preserved Versus Reduced Ejection Fraction: Evidence for Shared Metabolic Impairments in Clinical Heart Failure
46. Implications of Using Different Definitions on Outcomes in Worsening Heart Failure
47. Differential Response to Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Reduced or Preserved Ejection Fraction
48. Coenzyme Q10 and Heart Failure
49. Abstract 10990: Regulatory Implications of Different Definitions and Outcomes in Worsening Heart Failure
50. Abstract 17580: Angina Pectoris in Diabetic Patients: Insights From the Duke Databank for Cardiovascular Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.